Report cover image

In Vitro Diagnostics Business Outlook, 2026 - Volume 5, Issue 1 and 2

Published Jan 29, 2026
Length 30 Pages
SKU # KLI20810526

Description

The in vitro diagnostics (IVD) industry is a cornerstone of modern healthcare, empowering clinicians to detect disease, monitor health conditions, and guide treatment decisions with precision. As healthcare continues to evolve—driven by rising rates of chronic conditions such as diabetes and cardiovascular disease, along with ongoing and emerging infectious threats—the IVD market is undergoing constant change and growth.

In Vitro Diagnostics Business Outlook is a monthly intelligence publication designed to help industry professionals stay current in this fast-moving environment. Delivered in 12 issues annually, each issue focuses on a different segment of the IVD industry, providing timely insights, exclusive data, and in-depth analysis.

Featured Content

Each monthly issue provides:
  • Market Data and Forecasts
Detailed growth rates, market size, and market share to help identify emerging opportunities.
  • Comprehensive Market View
Coverage of key test categories and profiles of active companies across the IVD landscape.
  • M&A Activity Tracking
Updates on mergers, acquisitions, partnerships, and collaborations shaping the market.
  • Industry & Region Watch
Analysis of regional and segment-specific trends to support tailored strategic planning.
  • In-Depth News Analysis
Reporting on significant developments and events, including exclusive information not readily available elsewhere.

2026 Editorial Focus

Topics vary month to month, reflecting evolving industry priorities. In 2026, subscribers can expect issues dedicated to:
  • Reimbursement trends
  • Quality control reagents
  • Cardiac markers
  • STI point-of-care testing
  • Non-respiratory infectious diseases
  • An overall IVD market trend analysis
  • A forward-looking forecast of the respiratory testing market through 2027
  • And more!
By delivering focused, actionable intelligence directly to subscribers’ each month, In Vitro Diagnostics Business Outlook helps decision-makers anticipate market shifts, identify growth opportunities, and navigate the complexities of the global IVD industry with confidence.

Please Note: Single user allows for up to 3 users for this report.

Table of Contents

30 Pages
    • Overview of IVD Reimbursement
    • Outlook: Reimbursement
    • Briefings
    • Agilent Full Year Fiscal 2025 Sales up 7% in Business YOY
    • Mergers and Acquisitions
    • Partnerships and Collaborations
    • Industry Watch COVID-19/Flu Update
    • Australia
    • Announcements

Search Inside Report

How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.